--- title: "12 Health Care Stocks Moving In Tuesday's Intraday Session" type: "News" locale: "en" url: "https://longbridge.com/en/news/302452182.md" description: "During Tuesday's intraday session, several healthcare stocks experienced significant volatility. Top gainers included SCWorx (WORX) up 42.9%, Myriad Genetics (MYGN) up 36.85%, and Anbio Biotechnology (NNNN) up 22.32%. Conversely, major losers featured China SXT Pharmaceuticals (SXTC), which plummeted 41.5%, followed by CDT Equity (CDT) down 14.04% and Bristol-Myers Squibb Celegne Contingent Value Rights (CELGR) declining 10.01%." datetime: "2026-10-20T17:05:47.000Z" locales: - [zh-CN](https://longbridge.com/zh-CN/news/302452182.md) - [en](https://longbridge.com/en/news/302452182.md) - [zh-HK](https://longbridge.com/zh-HK/news/302452182.md) generator: "portal-rs" --- # 12 Health Care Stocks Moving In Tuesday's Intraday Session ### Gainers - **SCWorx** (NASDAQ:WORX) stock moved upwards by 42.9% to $3.83 during Tuesday's regular session. - **Myriad Genetics** (NASDAQ:MYGN) shares moved upwards by 36.85% to $5.76. The company's market cap stands at $397.6 million. - **Anbio Biotechnology** (NASDAQ:NNNN) stock increased by 22.32% to $4.0. The company's market cap stands at $143.5 million. - **Clene** (NASDAQ:CLNN) shares moved upwards by 20.66% to $3.97. The market value of their outstanding shares is at $46.7 million. - **Concord Medical Services** (NYSE:CCM) stock increased by 17.69% to $4.19. The company's market cap stands at $15.4 million. - **iBio** (NASDAQ:IBIO) stock rose 17.08% to $0.89. The company's market cap stands at $48.8 million. ### Losers - **China SXT Pharmaceuticals** (NASDAQ:SXTC) stock fell 41.5% to $0.07 during Tuesday's regular session. - **CDT Equity** (NASDAQ:CDT) shares decreased by 14.04% to $0.16. - **Bristol-Myers Squibb Company Celegne Contingent Value Rights** (NYSE:CELGR) stock declined by 10.01% to $0.1. - **NexGel** (NASDAQ:NXGL) shares declined by 9.83% to $5.23. The market value of their outstanding shares is at $2.8 million. - **DarioHealth** (NASDAQ:DRIO) shares declined by 9.8% to $4.05. The market value of their outstanding shares is at $43.9 million. - **BioVie** (NASDAQ:BIVI) stock decreased by 8.4% to $1.25. The company's market cap stands at $11.8 million. **See Also:** www.benzinga.com/money/best-healthcare-stocks/ This article was generated by Benzinga's automated content engine and reviewed by an editor. ### Related Stocks - [BIVI.US](https://longbridge.com/en/quote/BIVI.US.md) - [CCM.US](https://longbridge.com/en/quote/CCM.US.md) - [CDT.US](https://longbridge.com/en/quote/CDT.US.md) - [CELG.RT.US](https://longbridge.com/en/quote/CELG.RT.US.md) - [CLNN.US](https://longbridge.com/en/quote/CLNN.US.md) - [DRIO.US](https://longbridge.com/en/quote/DRIO.US.md) - [IBIO.US](https://longbridge.com/en/quote/IBIO.US.md) - [MYGN.US](https://longbridge.com/en/quote/MYGN.US.md) - [NNNN.US](https://longbridge.com/en/quote/NNNN.US.md) - [NXGL.US](https://longbridge.com/en/quote/NXGL.US.md) - [SXTC.US](https://longbridge.com/en/quote/SXTC.US.md) - [WORX.US](https://longbridge.com/en/quote/WORX.US.md) ## Related News & Research - [BioVie’s Bezisterim improves Parkinson’s symptoms in patients with elevated inflammation in Phase 2 trial](https://longbridge.com/en/news/302419260.md) - [Clene Seeks FDA Accelerated Approval for CNM-Au8 in ALS](https://longbridge.com/en/news/302286373.md) - [SCWorx Announces New Agreement with Healthcare System | WORX Stock News](https://longbridge.com/en/news/302301397.md) - [BioVie’s Bezisterim Improves Fatigue in More Severely Affected Long COVID Patients in Phase 2 Trial](https://longbridge.com/en/news/302286418.md) - [Clene Secures NIH Funding for ALS Therapy Program](https://longbridge.com/en/news/302406540.md) --- > **Disclaimer: This article is for reference only and does not constitute any investment advice.**